Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype:

Ana Canseco-Alba1, Branden Sanabria2, Mariam Hammouda2

  • 1Dirección de Investigación, Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez", Mexico City, Mexico.

Frontiers in Psychiatry
|February 25, 2022
PubMed

Insights

Adolescent mice lacking cannabinoid CB2 receptors (CB2R) in dopamine neurons exhibit hyperactivity and impulsivity, suggesting a potential model for attention deficit hyperactivity disorder (ADHD). Amphetamine paradoxically reduced hyperactivity in these DAT-Cnr2 mice.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Behavioral Science

Background:

  • Cannabinoid CB2 receptors (CB2R) play a role in the central nervous system.
  • Dopamine neurons are implicated in attention and impulse control.
  • Understanding CB2R function in dopaminergic pathways is crucial for neurological disorders.

Purpose of the Study:

  • To investigate the behavioral phenotype of DAT-Cnr2 conditional knockout (cKO) mice lacking CB2R in midbrain dopamine neurons.
  • To assess the effects of amphetamine on locomotor activity and behavior in these mice.
  • To explore the potential of DAT-Cnr2 cKO mice as a model for attention deficit hyperactivity disorder (ADHD).

Main Methods:

  • Locomotor activity analysis using Open Field (OF) and Elevated Plus-Maze (EPM) tests.
  • Novel Object Recognition (NOR) task to assess recognition memory.
  • Assessment of impulsivity and decision-making using Cliff Avoidance Reaction (CAR) and Delay Decision Making (DDM) tasks.
  • Immunohistochemical analysis of microglia activation (Cd11b).

Main Results:

  • DAT-Cnr2 cKO mice showed increased locomotor activity and reduced anxiety-like behavior compared to Wild Type (WT) mice.
  • Amphetamine (2 mg/kg) paradoxically reduced locomotor activity in DAT-Cnr2 cKO mice while increasing it in WT mice.
  • DAT-Cnr2 cKO mice displayed increased impulsivity and risky behavior, with impaired delay-based decision-making.
  • Enhanced microglia activation was observed in the hippocampus of DAT-Cnr2 cKO mice, suggesting neuro-immune involvement.

Conclusions:

  • Cell-type specific deletion of CB2R in midbrain dopaminergic neurons leads to hyperactivity, impulsivity, and altered amphetamine response.
  • DAT-Cnr2 cKO mice present a valuable model for studying the neurobiological underpinnings of ADHD.
  • CB2R signaling in dopaminergic neurons may modulate neuro-immune responses relevant to ADHD pathophysiology.